Cytek Biosciences to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025

Company Overview - Cytek Biosciences, Inc. is a leading cell analysis solutions company that specializes in high-resolution, high-content, and high-sensitivity cell analysis using its patented Full Spectrum Profiling™ (FSP™) technology [2][3] - The company's product offerings include the Cytek Aurora™ and Northern Lights™ systems, the Cytek Aurora CS cell sorter, and the Cytek Orion™ reagent cocktail preparation system, among others [2][3] Financial Announcement - Cytek Biosciences will report its financial results for the fourth quarter and full year 2024 after market close on February 27, 2025 [1] - A conference call will be held at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss the results, business developments, and outlook [1] Communication Channels - The company utilizes its website, LinkedIn page, and X (formerly Twitter) account for distributing information about its products, financial announcements, and other material information [4]